Gerresheimer Continues to Invest in Prefilled Syringes

DUSSELDORF, Germany, November 25, 2010 /PRNewswire/ --

- A Fourth Production Line for Prefilled Glass Syringes is Planned for the Bünde Plant (Germany)

- Investment Total of Approximately EUR 20 Million

- Completion in 2012

Gerresheimer AG, one of the world's leading suppliers to the pharma and healthcare industry, is making further investments in the growth market for prefilled syringes. The three existing production lines for RTF(R) syringes (Ready-To-Fill syringes) at the Bünde plant (Germany) are now to be supplemented by an additional, latest-generation line.

Double-digit rates of annual growth are being recorded in the prefilled glass syringe market. Gerresheimer, the clear number two in the global market, is now stepping up its production capacity and investing around EUR 20 million in a fourth production line for prefilled syringes which will be completed in 2012. The new line will then add an annual capacity of up to 120 million syringes.

"We are a successful supplier of syringes to pharmaceutics customers around the world. Now we are investing in this fast-growing market again to consolidate our global market position further. The technical know-how of our Syringe Competence Centre in Bünde makes it the ideal platform for further growth," said Uwe Röhrhoff, CEO of Gerresheimer AG.

More information on prefilled syringes at: http://www.presseportal.de/go2/spritzensysteme_engl

Gerresheimer AG Benrather Strasse 18 - 20 40213 Düsseldorf Germany Jens Kürten Director Corporate Communication & Marketing Telephone [phone] Telefax [phone] E-Mail [e-mail]

Gerresheimer AG

Gerresheimer AG, Benrather Strasse 18 - 20, 40213 Düsseldorf, Germany, Jens Kürten, Director Corporate Communication & Marketing, Telephone [phone], Telefax [phone], E-Mail [e-mail]